Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by scarlet1967


T.TH

Tesamorelin reduces IGFBP-6

This article published few days ago is describing the role of IGFBP-6 in...

April 17, 2022

T.TH

Scientist researcher

It has been a while since I checked on their new recruits but this lady hired...

April 17, 2022

T.TH

RE:RE:RE:RE:RE:Cash position

It's worth remembering these are late stage cancer patients with less...

April 13, 2022

T.TH

Taimed news

There was a question about manufacturing issues in China today due to recent...

April 13, 2022

T.TH

Quick Summary

    Oncology: No DLTs so far at 300mg/m2, 3 patients...

April 13, 2022

T.TH

RE:RE:RE:Fins are out..

   "We are currently exploring alternatives to redeem the...

April 13, 2022

T.TH

France must pay

            “HIV...

April 10, 2022

T.TH

Published yesterday

https://mdpi-res.com/d_attachment/cancers/cancers-14-01877/article_deploy...

April 9, 2022

T.TH

ExcellThera

They have a new recruit, it appears to be the CMO of the above company. Their...

April 1, 2022

T.TH

Taimed news

http://www.taimedbiologics.com/news/info/101

April 1, 2022

T.TH

Good article

        “Entry inhibitors are a...

March 23, 2022

T.TH

Get on with it!

      This was published today so yes more and...

March 16, 2022

T.TH

Trogarzo, expensive but safe and effective a life saver

“Dr. Melanie Thompson: Ibalizumab is an entry inhibitor that has activity...

March 15, 2022

T.TH

RE:RE:HIV-2

Hey Leo, I believe they are doing a good job marketing their drugs already...

March 13, 2022

T.TH

HIV-2

They have published the revised study (March 8) re the efficacy of Trogarzo...

March 12, 2022

T.TH

RE:RE:Good exposure

I believe you are correct. Just good to see the media in China picked it up...

March 10, 2022

T.TH

Good exposure

FDA-approved drug reverses signs of liver disease in people with HIV  ...

March 10, 2022

T.TH

EDEN Biologics

“We license-in innovative new molecules for co-development that we believe...

March 10, 2022

T.TH

Adiposity and cognitive function in the general public

Not long ago it was a study conforming: “Intensification of ART in people...

March 6, 2022

T.TH

Roche still is chasing...

Roche started an early collaboration with bicycle (February 2020): “Bicycle...

March 6, 2022